SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000891293-17-000142
Filing Date
2017-12-11
Accepted
2017-12-11 16:49:57
Documents
1
Effectiveness Date
2017-12-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A cti-defa14adefinitivenotic.htm DEFA14A 42076
  Complete submission text file 0000891293-17-000142.txt   43183
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-28386 | Film No.: 171250005
SIC: 2834 Pharmaceutical Preparations